Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017
Current Assets:
Cash and cash equivalents	$ 524.6	$ 524.4
Accounts receivable, less allowance for doubtful accounts	1,262.7	1,544.1
Inventories	2,219.5	2,068.3
Prepaid expenses and other current assets	506.5	428.0
Total Current Assets	4,513.3	4,564.8
Property, plant and equipment, net	2,002.4	2,038.6
Goodwill	10,583.6	10,668.4
Intangible assets, net	7,837.4	8,353.4
Other assets	445.3	388.8
Total Assets	25,382.0	26,014.0
Current Liabilities:
Accounts payable	345.8	330.2
Income taxes payable	196.2	165.2
Other current liabilities	1,249.2	1,349.3
Current portion of long-term debt	600.0	1,225.0
Total Current Liabilities	2,391.2	3,069.7
Deferred income taxes	1,054.0	1,101.5
Long-term income tax payable	782.0	744.0
Other long-term liabilities	334.4	445.8
Long-term debt	8,597.4	8,917.5
Total Liabilities	13,159.0	14,278.5
Commitments and Contingencies (Note 15)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 307.8 million shares issued in 2018 (306.5 million in 2017)	3.1	3.1
Paid-in capital	8,662.3	8,514.9
Retained earnings	10,441.2	10,022.8
Accumulated other comprehensive loss	(168.1)	(83.2)
Treasury stock, 103.8 million shares in 2018 (103.9 million shares in 2017)	(6,721.7)	(6,721.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,216.8	11,735.8
Noncontrolling interest	6.2	(0.3)
Total Stockholders' Equity	12,223.0	11,735.5
Total Liabilities and Stockholders' Equity	$ 25,382.0	$ 26,014.0